genedrive plc (LON:GDR – Get Free Report) fell 9.1% on Thursday . The stock traded as low as GBX 3.70 ($0.05) and last traded at GBX 3.75 ($0.05). 19,430,984 shares changed hands during mid-day trading, an increase of 36% from the average session volume of 14,246,880 shares. The stock had previously closed at GBX 4.13 ($0.05).
genedrive Trading Down 5.7 %
The company has a debt-to-equity ratio of 8.57, a current ratio of 1.63 and a quick ratio of 5.52. The company’s 50 day moving average is GBX 2.32 and its two-hundred day moving average is GBX 3.97. The firm has a market cap of £6.00 million, a P/E ratio of -96.25 and a beta of 0.04.
genedrive Company Profile
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Further Reading
- Five stocks we like better than genedrive
- How is Compound Interest Calculated?
- Humana Slides on Profitability Concerns Despite Q2 Earnings Beat
- Insider Buying Explained: What Investors Need to Know
- Procter & Gamble Stock Drops Despite Earnings Beat – What to Know
- Most Volatile Stocks, What Investors Need to Know
- Financial Sector Shines as Key Players Continue to Beat Earnings
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
